Current Edition


On a roll, Sanofi raises Dupixent’s peak sales target to €13B-plus

Over the years, as Sanofi and Regeneron’s Dupixent racked up new indications and approached the French pharma giant’s 10 billion euro peak sales goal, analysts had started …

Continue Reading →
clinical trial

Pfizer now expects COVID vaccine sales to reach $33.5B this year, a whopping $7.5B bump from its estimate 3 months ago

We’re seeing victory laps these days during the Summer Olympic Games. Now it’s Pfizer’s turn. Three months after estimating 2021 revenues for its COVID-19 vaccine …

Continue Reading →